Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain
Nina Rieckmann(Humboldt-Universität zu Berlin), Theodora Benedek(Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș), Tomasz Harań(Wojewódzki Szpital Specjalistyczny we Wrocławiu), Daniel Preuß(Humboldt-Universität zu Berlin), Bruno García del Blanco(Universitat Autònoma de Barcelona), Katriona Brooksbank(British Heart Foundation), Michael Woinke(Leipzig Heart Institute), Konrad Neumann(Humboldt-Universität zu Berlin), Ioana Rodean, Malgorzata Ilnicka Suckiel(Wojewódzki Szpital Specjalistyczny we Wrocławiu), Paolo Ibes(Humboldt-Universität zu Berlin), Andrejs Ērglis(Pauls Stradiņš Clinical University Hospital), Antti Saraste(University of Turku), Henryk Dreger(Humboldt-Universität zu Berlin), Mark Hensey(St. Vincent's University Hospital), Josef Veselka(Universitat Autònoma de Barcelona), Audronė Vaitiekienė(Hospital of Lithuanian University of Health Sciences Kaunas Clinics), Thomas Zelesny(Alb Fils Kliniken), Nada Čemerlić Adjić(University of Novi Sad), Luca Saba(University of Cagliari), Thomas Engstrøm(University of Copenhagen), Massimo Mancone(Sapienza University of Rome), Marco Francone, Jonathan D. Dodd(St. Vincent's University Hospital), Stephen Schröder(Alb Fils Kliniken), Rita Faria(Centro Hospitalar de Vila Nova de Gaia), Vojtěch Suchánek(University Hospital in Motol), Damien Collison(Golden Jubilee National Hospital), Bruno Loi(Azienda Ospedaliera G. Brotzu), Klaus F. Kofoed(University of Copenhagen), Juhani Knuuti(University of Turku), Marina Berzina(Pauls Stradiņš Clinical University Hospital), Laura Zajančkauskienė(Hospital of Lithuanian University of Health Sciences Kaunas Clinics), Matthias Gutberlet(Leipzig Heart Institute), José F. Rodríguez‐Palomares(Universitat Autònoma de Barcelona), Erica Thwaite(University of Liverpool), Patrick Donnelly, Béla Merkely(Semmelweis University), Adriane E. Napp(Humboldt-Universität zu Berlin), Gudrun Feuchtner(Innsbruck Medical University), Imre Benedek(Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș), Fabian Plank(Innsbruck Medical University), Gershan Davis(University of Liverpool), Pál Maurovich‐Horvat(Semmelweis University), Cezary Kępka(Institute of Cardiology), Vasco Gama-Ribeiro(Centro Hospitalar de Vila Nova de Gaia), Mariusz Kruk(Institute of Cardiology), Sarah Feger(Humboldt-Universität zu Berlin), Filip Adjić(University of Novi Sad), Peter Ball(University of St Andrews)
Cited by 31
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k